Wellbeing improving technologies
Chronic pain affects 1.5 billion people globally. The economic cost in the US is more than heart disease, cancer, and diabetes combined.
We’re developing therapeutics for pain with less tolerance, dependence and withdrawal.
Solving the world’s biggest problems requires a better science of wellbeing.
Our research
More paths to
better medicines.
Our research pursues multiple independent paths to radically better pain therapeutics. Our interests span chronic and acute pain, as well as pain associated with specific conditions.
We are based in the San Francisco Bay Area and conduct research and development for our preclinical programs in our own facilities.
Academic partner
Our team
-
Curran Janssens
CEO
-
Garrett Soiland
Operations
-
Adar Kahiri
Small Molecules
-
Louis Arge
Molecular Biology